Rapid Micro Biosystems (RPID) Assets Average (2021 - 2026)
Rapid Micro Biosystems (RPID) reported Assets Average of $68.6 million for Q1 2026, down 25.27% on a YoY basis from $91.8 million in Q1 2025, and down 13.84% sequentially from $79.6 million in Q4 2025.
Rapid Micro Biosystems (RPID) Assets Average (2021 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 6 years of Assets Average data on file, last reported at $68.6 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 25.27% year-over-year to $68.6 million; the trailing twelve-month figure through Mar 2026 stood at $68.6 million (down 25.27% YoY), and the FY2025 full-year result was $86.5 million, down 28.39% from the prior year.
- Assets Average eased to $68.6 million in Q1 2026, from $79.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $235.6 million in Q1 2022 to a low of $68.6 million in Q1 2026.
- A 5-year average of $140.4 million and a median of $135.6 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average grew 8.96% in 2022 and sank 34.23% in 2025, its largest moves.
- Tracing RPID's Assets Average over 5 years: stood at $196.3 million in 2022, then decreased by 25.21% to $146.8 million in 2023, then plunged by 30.52% to $102.0 million in 2024, then decreased by 21.94% to $79.6 million in 2025, then retreated by 13.84% to $68.6 million in 2026.
- Business Quant data shows RPID's Assets Average at $68.6 million in Q1 2026, $79.6 million in Q4 2025, and $80.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.49 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.64 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.57 Bn |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 68.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.61 Mn |
| Dec 31, 2025 | 79.63 Mn |
| Sep 30, 2025 | 80.00 Mn |
| Jun 30, 2025 | 80.51 Mn |
| Mar 31, 2025 | 91.80 Mn |
| Dec 31, 2024 | 102.01 Mn |
| Sep 30, 2024 | 111.46 Mn |
| Jun 30, 2024 | 122.41 Mn |
| Mar 31, 2024 | 135.59 Mn |
| Dec 31, 2023 | 146.81 Mn |
| Sep 30, 2023 | 155.55 Mn |
| Jun 30, 2023 | 167.11 Mn |
| Mar 31, 2023 | 181.97 Mn |
| Dec 31, 2022 | 196.28 Mn |
| Sep 30, 2022 | 209.03 Mn |
| Jun 30, 2022 | 223.10 Mn |
| Mar 31, 2022 | 235.61 Mn |
| Dec 31, 2021 | 247.80 Mn |
| Sep 30, 2021 | 191.83 Mn |